Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptide-Drug Conjugates: A New Hope for Cancer Management
Vivek P. Chavda, Hetvi K. Solanki, Majid Davidson, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7232-7232
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Nanoparticle-Based Delivery Systems for Vaccines
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 107
Peptides as multifunctional players in cancer therapy
Sri Murugan Poongkavithai Vadevoo, Smriti Gurung, Hyun‐Su Lee, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 6, pp. 1099-1109
Open Access | Times Cited: 59
Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy
Shuxin Yan, Jintong Na, Xiyu Liu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 248-248
Open Access | Times Cited: 22
Peptide-drug conjugates: A new paradigm for targeted cancer therapy
Mo Wang, Jiawei Liu, Mingjing Xia, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116119-116119
Closed Access | Times Cited: 21
Nanoparticles in cancer diagnosis and treatment: Progress, challenges, and opportunities
Niloufar Rashidi, Majid Davidson, Vasso Apostolopoulos, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 95, pp. 105599-105599
Open Access | Times Cited: 14
Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment
Juwon Yang, Hyunsu Bae
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 9, pp. 1996-2004
Open Access | Times Cited: 23
Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic
Syed Faheem Askari Rizvi, Lin‐Jie Zhang, Haixia Zhang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 2, pp. 309-334
Open Access | Times Cited: 11
Peptide–Drug Conjugates: An Emerging Direction for the Next Generation of Peptide Therapeutics
Trevor T. Dean, Juliet Jelú-Reyes, A’Lester C. Allen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1641-1661
Closed Access | Times Cited: 11
Covalent conjugation and non-covalent complexation strategies for intracellular delivery of proteins using cell-penetrating peptides
Yasaman Behzadipour, Shiva Hemmati
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116910-116910
Open Access | Times Cited: 8
Engineering peptide drug therapeutics through chemical conjugation and implication in clinics
Syed Faheem Askari Rizvi, Haixia Zhang, Quan Fang
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2420-2471
Closed Access | Times Cited: 6
The validation and clinical bioanalysis of the Bicycle® Toxin Conjugate zelenectide pevedotin in human plasma
Joseph Tweed, Fern Adams-Dam, Justin Bader, et al.
Bioanalysis (2025), pp. 1-9
Closed Access
Peptides on patrol: Carrier systems for targeted delivery
Vivek P. Chavda, Joanna Bojarska
Progress in molecular biology and translational science (2025)
Closed Access
Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer
Longkun Wang, Chunqian Zhao, Lu Lu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4646-4646
Open Access | Times Cited: 18
Recent advances in the peptide-based biosensor designs
Yue Xiao, Ting Zhang, Houjin Zhang
Colloids and Surfaces B Biointerfaces (2023) Vol. 231, pp. 113559-113559
Closed Access | Times Cited: 14
Development of a Targeted SN-38-Conjugate for the Treatment of Glioblastoma
Perpetue Bataille Backer, Tayo Alex Adekiya, Yushin Kim, et al.
ACS Omega (2024) Vol. 9, Iss. 2, pp. 2615-2628
Open Access | Times Cited: 5
Biological Activity of Natural and Synthetic Peptides as Anticancer Agents
Luana Vittoria Bauso, Valeria La Fauci, S. Munaò, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7264-7264
Open Access | Times Cited: 5
Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?
Baochen Zhang, Mo Wang, Li Sun, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11469-11487
Closed Access | Times Cited: 5
Structure-guided design and cloning of peptide inhibitors targeting CDK9/cyclin T1 protein-protein interaction
Mohammad Sadegh Taghizadeh, Mohsen Taherishirazi, Ali Niazi‎, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Peptide cargo administration: current state and applications
Harsha Rohira, Aditi Arora, Prasanjeet Kaur, et al.
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 10, pp. 3153-3181
Open Access | Times Cited: 13
Drug Delivery Strategies for the Treatment of Pancreatic Cancer
Oluwabukunmi Olajubutu, Omotola D. Ogundipe, Sarafadeen A. Adebayo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1318-1318
Open Access | Times Cited: 12
Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes
Vivek P. Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, et al.
Cancer Reports (2023) Vol. 6, Iss. S1
Open Access | Times Cited: 12
Improving the efficacy of peptide vaccines in cancer immunotherapy
Fatemeh Zahedipour, Khadijeh Jamialahmadi, Parvin Zamani, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110721-110721
Closed Access | Times Cited: 12
Advances in targeted therapy for pancreatic cancer
Lin Xing, Linlin Lv, Jiaqi Ren, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115717-115717
Open Access | Times Cited: 12
Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide–Drug Conjugates
Jacopo Gomena, Balázs Vári, Rita Oláh-Szabó, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3400-3400
Open Access | Times Cited: 11
Theranostic applications of peptide-based nanoformulations for growth factor defective cancers
Arnab Ghosh, Priyanka Maske, Vinay Patel, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129151-129151
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top